BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 32524991)

  • 21. [Short-term efficacy of anti-IgE monoclonal antibody in patients with recurrent chronic rhinosinusitis with nasal polyps combined with asthma].
    Shen S; Lou HF; Yan B; Wang Y; Cao FF; Xiong W; Wang CS; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 56(10):1035-1041. PubMed ID: 34666463
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of sodium hyaluronate added to topical corticosteroids in chronic rhinosinusitis with nasal polyposis.
    Cantone E; Iengo M
    Am J Rhinol Allergy; 2016 Sep; 30(5):340-343. PubMed ID: 27302143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
    Price CPE; Guo A; Stevens WW; Cousens L; Vu TT; Suh LA; Erickson KA; Conley D; Grammer LC; Kern RC; Tan BK; Kato A; Schleimer RP; Smith SS; Welch KC; Peters AT
    Clin Exp Allergy; 2022 Jul; 52(7):859-867. PubMed ID: 35524339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab is effective in nasal polyposis with or without asthma, a real-life study.
    Tat TS
    World Allergy Organ J; 2022 Aug; 15(8):100670. PubMed ID: 36017064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: a double-blind, randomized, placebo-controlled trial.
    Zhou B; He G; Liang J; Cheng L; Mehta A; Liu S; Yu W; Wang Z; Han D
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):88-94. PubMed ID: 26575524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye.
    Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174
    [No Abstract]   [Full Text] [Related]  

  • 28. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
    Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
    Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE.
    Mullol J; Lund VJ; Wagenmann M; Han JK; Sousa AN; Smith SG; Mayer B; Chan RH; Fokkens WJ
    Rhinology; 2024 Jun; 62(3):320-329. PubMed ID: 38217844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
    Hopkins C; Mullol J; Khan AH; Lee SE; Wagenmann M; Hellings P; Fokkens W; Msihid J; Nair R; Kamat S; Nash S; Radwan A; Jacob-Nara JA; Deniz Y; Rowe PJ
    Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1173-1182. PubMed ID: 38156522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.
    Forwith KD; Han JK; Stolovitzky JP; Yen DM; Chandra RK; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK
    Int Forum Allergy Rhinol; 2016 Jun; 6(6):573-81. PubMed ID: 26992115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
    Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study.
    Maza-Solano J; Callejon-Leblic A; Martin-Jimenez D; Moreno-Luna R; Gonzalez-Garcia J; Cuvillo A; Sanchez-Gomez S
    Curr Allergy Asthma Rep; 2023 Oct; 23(10):555-566. PubMed ID: 37644255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
    Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
    J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis.
    Small CB; Hernandez J; Reyes A; Schenkel E; Damiano A; Stryszak P; Staudinger H; Danzig M
    J Allergy Clin Immunol; 2005 Dec; 116(6):1275-81. PubMed ID: 16337459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.
    Kern RC; Stolovitzky JP; Silvers SL; Singh A; Lee JT; Yen DM; Iloreta AMC; Langford FPJ; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK;
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):471-481. PubMed ID: 29350840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
    Han JK; Bachert C; Lee SE; Hopkins C; Heffler E; Hellings PW; Peters AT; Kamat S; Whalley D; Qin S; Nelson L; Siddiqui S; Khan AH; Li Y; Mannent LP; Guillemin I; Chuang CC
    Laryngoscope; 2022 Feb; 132(2):265-271. PubMed ID: 34850966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
    BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiofilm effects of topical corticosteroids and intranasal saline in patients with chronic rhinosinusitis with nasal polyps depend on bacterial species and their biofilm-forming capacity.
    Cirkovic I; Pavlovic B; Bozic DD; Jotic A; Bakic L; Milovanovic J
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1897-1903. PubMed ID: 28116488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis.
    Cai S; Xu S; Lou H; Zhang L
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1876-1886.e7. PubMed ID: 35272073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.